104 related articles for article (PubMed ID: 3182429)
1. Antimicrobial activity of LY163892, an orally administered 1-carbacephem.
Jones RN; Barry AL
J Antimicrob Chemother; 1988 Sep; 22(3):315-20. PubMed ID: 3182429
[TBL] [Abstract][Full Text] [Related]
2. Comparative in-vitro activity of a new oral carbacephem, LY163892.
Howard AJ; Dunkin KT
J Antimicrob Chemother; 1988 Oct; 22(4):445-56. PubMed ID: 3060458
[TBL] [Abstract][Full Text] [Related]
3. Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephem.
Jones RN; Barry AL
J Clin Microbiol; 1988 Apr; 26(4):770-3. PubMed ID: 3259247
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity and beta-lactamase stability of LY163892.
Cao C; Chin NX; Neu HC
J Antimicrob Chemother; 1988 Aug; 22(2):155-65. PubMed ID: 3263352
[TBL] [Abstract][Full Text] [Related]
5. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Johnson DM; Jones RN
Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):181-8. PubMed ID: 1396735
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity and beta-lactamase stability of LY163892.
Pelosi E; Fontana R
Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):549-51. PubMed ID: 3141170
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
Tomatsu K; Ando S; Masuyoshi S; Kondo S; Hirano M; Miyaki T; Kawaguchi H
J Antibiot (Tokyo); 1987 Aug; 40(8):1175-83. PubMed ID: 3500158
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibilities of common pediatric pathogens to LY163892.
Shelton S; Nelson JD
Antimicrob Agents Chemother; 1988 Feb; 32(2):268-70. PubMed ID: 3129989
[TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of cefaclor (author's transl)].
Knothe H
Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
Neu HC; Chin NX; Labthavikul P
Antimicrob Agents Chemother; 1986 Sep; 30(3):423-8. PubMed ID: 3490827
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis.
Doern GV; Vautour R; Parker D; Tubert T; Torres B
Antimicrob Agents Chemother; 1991 Jul; 35(7):1504-7. PubMed ID: 1929318
[TBL] [Abstract][Full Text] [Related]
14. Influence of storage and susceptibility test conditions on stability and activity of LY163892 and four other cephalosporins.
Jorgensen JH; Redding JS; Maher LA
Antimicrob Agents Chemother; 1988 Oct; 32(10):1477-80. PubMed ID: 3190179
[TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.
Neu HC; Chin NX; Labthavikul P
Antimicrob Agents Chemother; 1984 Aug; 26(2):174-80. PubMed ID: 6333207
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
Kamimura T; Kojo H; Matsumoto Y; Mine Y; Goto S; Kuwahara S
Antimicrob Agents Chemother; 1984 Jan; 25(1):98-104. PubMed ID: 6561017
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
Bill NJ; Washington JA
Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of LY163892, cefaclor, and cefuroxime.
Knapp CC; Washington JA
Antimicrob Agents Chemother; 1988 Jan; 32(1):131-3. PubMed ID: 3348605
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
Neu HC
Pediatr Infect Dis J; 1987 Oct; 6(10):958-62. PubMed ID: 3696836
[TBL] [Abstract][Full Text] [Related]
20. In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Jones RN; Barry AL
Chemioterapia; 1988 Oct; 7(5):283-6. PubMed ID: 3147148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
